Clinical trial
Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode…
NCT00189436 · Deborah Gentile, Other · Completed
Key facts
| NCT number | NCT00189436 |
|---|---|
| Title | Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children |
| Official title | A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency Department/Outpatient Care Facility |
| Acronym | BudER |
| Lead sponsor | Deborah Gentile, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Nebulized Budesonide, Usual care (albuterol with or without oral steroid) |
| Enrollment | 61 |
| Start date | Mar 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: